These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11926276)

  • 1. Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity.
    O'Shea RD; Fodera MV; Apricó K; Dehnes Y; Danbolt NC; Crawford D; Beart PM
    Neurochem Res; 2002 Feb; 27(1-2):5-13. PubMed ID: 11926276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
    Apricò K; Beart PM; Crawford D; O'Shea RD
    J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes.
    Ye ZC; Sontheimer H
    Glia; 1999 Feb; 25(3):270-81. PubMed ID: 9932873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions.
    Bonde C; Sarup A; Schousboe A; Gegelashvili G; Zimmer J; Noraberg J
    Neurochem Int; 2003; 43(4-5):371-80. PubMed ID: 12742081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
    Molz S; Tharine DC; Decker H; Tasca CI
    Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo.
    Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L
    Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal.
    Anderson CM; Bridges RJ; Chamberlin AR; Shimamoto K; Yasuda-Kamatani Y; Swanson RA
    J Neurochem; 2001 Dec; 79(6):1207-16. PubMed ID: 11752061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole.
    Erickson JD
    J Neurochem; 2017 Jul; 142(1):29-40. PubMed ID: 28423185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters.
    Velly LJ; Guillet BA; Masmejean FM; Nieoullon AL; Bruder NJ; Gouin FM; Pisano PM
    Anesthesiology; 2003 Aug; 99(2):368-75. PubMed ID: 12883409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures.
    Vornov JJ; Tasker RC; Park J
    Exp Neurol; 1995 May; 133(1):7-17. PubMed ID: 7541369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliotoxicity in hippocampal cultures is induced by transportable, but not by nontransportable, glutamate uptake inhibitors.
    Guiramand J; Martin A; de Jesus Ferreira MC; Cohen-Solal C; Vignes M; Récasens M
    J Neurosci Res; 2005 Jul; 81(2):199-207. PubMed ID: 15931685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin.
    Jabaudon D; Shimamoto K; Yasuda-Kamatani Y; Scanziani M; Gähwiler BH; Gerber U
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8733-8. PubMed ID: 10411944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for neuronal origin and metabotropic receptor-mediated regulation of extracellular glutamate and aspartate in rat striatum in vivo following electrical stimulation of the prefrontal cortex.
    Lada MW; Vickroy TW; Kennedy RT
    J Neurochem; 1998 Feb; 70(2):617-25. PubMed ID: 9453555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-expression of the human EAAT2 glutamate transporter within neurons of mouse organotypic hippocampal slice cultures leads to increased vulnerability of CA1 pyramidal cells.
    Selkirk JV; Stiefel TH; Stone IM; Naeve GS; Foster AC; Poulsen DJ
    Eur J Neurosci; 2005 Apr; 21(8):2291-6. PubMed ID: 15869527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [(3)H]-(2S,4R)-4-methylglutamate and [(3)H]D-aspartate as ligands for binding and autoradiographic analyses of glutamate transporters.
    Apricò K; Beart PM; Crawford D; O'shea RD
    Neurochem Int; 2007 Dec; 51(8):507-16. PubMed ID: 17590480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential pattern of neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity.
    Gerardo-Nava J; Mayorenko II; Grehl T; Steinbusch HW; Weis J; Brook GA
    J Chem Neuroanat; 2013 Nov; 53():11-7. PubMed ID: 24126226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective cap over CA1 synapses: extrasynaptic glutamate does not reach the postsynaptic density.
    Lozovaya N; Melnik S; Tsintsadze T; Grebenyuk S; Kirichok Y; Krishtal O
    Brain Res; 2004 Jun; 1011(2):195-205. PubMed ID: 15157806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens.
    Xi ZX; Baker DA; Shen H; Carson DS; Kalivas PW
    J Pharmacol Exp Ther; 2002 Jan; 300(1):162-71. PubMed ID: 11752112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.